153 related articles for article (PubMed ID: 34229248)
1. Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model.
Hsu SH; Cheng AC; Chang TY; Pao LH; Hsiong CH; Wang HJ
Biomed Pharmacother; 2021 Sep; 141():111855. PubMed ID: 34229248
[TBL] [Abstract][Full Text] [Related]
2. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
Wang HJ; Benet LZ
Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
[TBL] [Abstract][Full Text] [Related]
3. Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance.
Schulz Pauly JA; Wang J; Phipps CJ; Kalvass JC
Drug Metab Dispos; 2023 Aug; 51(8):1046-1052. PubMed ID: 37188529
[TBL] [Abstract][Full Text] [Related]
4. Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.
Yan Z; Ma L; Carione P; Huang J; Hwang N; Kenny JR; Hop CECA
J Pharm Sci; 2024 Apr; 113(4):1094-1112. PubMed ID: 38220087
[TBL] [Abstract][Full Text] [Related]
5. Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.
Rowland M; Leitch D; Fleming G; Smith B
J Pharmacokinet Biopharm; 1984 Apr; 12(2):129-47. PubMed ID: 6491897
[TBL] [Abstract][Full Text] [Related]
6. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data.
Dong J; Park MS
Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979
[TBL] [Abstract][Full Text] [Related]
7. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.
Ahmad AB; Bennett PN; Rowland M
J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930
[TBL] [Abstract][Full Text] [Related]
8. Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?
Sodhi JK; Wang HJ; Benet LZ
Drug Metab Dispos; 2020 Jul; 48(7):537-543. PubMed ID: 32305951
[TBL] [Abstract][Full Text] [Related]
9. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
10. Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality?
Pang KS; Han YR; Noh K; Lee PI; Rowland M
Biochem Pharmacol; 2019 Nov; 169():113596. PubMed ID: 31398312
[TBL] [Abstract][Full Text] [Related]
11. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A
Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632
[TBL] [Abstract][Full Text] [Related]
12. Application of a convective-dispersion model to predict in vivo hepatic clearance from in vitro measurements utilizing cryopreserved human hepatocytes.
Niro R; Byers JP; Fournier RL; Bachmann K
Curr Drug Metab; 2003 Oct; 4(5):357-69. PubMed ID: 14529368
[TBL] [Abstract][Full Text] [Related]
13. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
Poulin P; Bteich M; Haddad S
J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
[TBL] [Abstract][Full Text] [Related]
14. Evidence of the need for modified well-stirred model in vitro to in vivo extrapolation.
Chang TY; Wang HJ; Hsu SH; Chang ML; Kao LT; Pao LH
Eur J Pharm Sci; 2022 Oct; 177():106268. PubMed ID: 35901930
[TBL] [Abstract][Full Text] [Related]
15. Prediction of human hepatic clearance using an in vitro plated hepatocyte clearance model.
Chao P; Barminko J; Novik E; Han Y; Maguire T; Cheng KC
Drug Metab Lett; 2009 Dec; 3(4):296-307. PubMed ID: 20041832
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.
Ito K; Houston JB
Pharm Res; 2004 May; 21(5):785-92. PubMed ID: 15180335
[TBL] [Abstract][Full Text] [Related]
17. Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo.
Miyauchi S; Kim SJ; Lee W; Sugiyama Y
Pharmacol Ther; 2022 Jan; 229():107938. PubMed ID: 34171335
[TBL] [Abstract][Full Text] [Related]
18. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.
Tess DA; Ryu S; Di L
Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289
[TBL] [Abstract][Full Text] [Related]
19. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
Chow FS; Piekoszewski W; Jusko WJ
Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
[TBL] [Abstract][Full Text] [Related]
20. In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction.
Bowman CM; Benet LZ
J Pharm Sci; 2019 Jul; 108(7):2500-2504. PubMed ID: 30817922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
